Article Information
vol. 8 no. 1
Published By
Online ISSN
History
- Received September 6, 2021
- Accepted January 19, 2022
- Published online March 14, 2022.
Article Versions
- previous version (February 18, 2022 - 02:55).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- 1Clinical Development, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 2Patient Centered Science, Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 3Clinical Development, Research and Late Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- Corresponding author: Carla A. Da Silva (Carla.DaSilva{at}astrazeneca.com)
Funding
AstraZeneca